These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 3688085

  • 1. Hypoxia-induced fetoplacental vasoconstriction in perfused human placental cotyledons.
    Howard RB, Hosokawa T, Maguire MH.
    Am J Obstet Gynecol; 1987 Nov; 157(5):1261-6. PubMed ID: 3688085
    [Abstract] [Full Text] [Related]

  • 2. Role of the L-arginine nitric oxide pathway in hypoxic fetoplacental vasoconstriction.
    Byrne BM, Howard RB, Morrow RJ, Whiteley KJ, Adamson SL.
    Placenta; 1997 Nov; 18(8):627-34. PubMed ID: 9364597
    [Abstract] [Full Text] [Related]

  • 3. Fetoplacental vascular tone during fetal circuit acidosis and acidosis with hypoxia in the ex vivo perfused human placental cotyledon.
    Hoeldtke NJ, Napolitano PG, Moore KH, Calhoun BC, Hume RF.
    Am J Obstet Gynecol; 1997 Nov; 177(5):1088-92. PubMed ID: 9396899
    [Abstract] [Full Text] [Related]

  • 4. Control of human placental blood flow.
    Howard RB.
    Med Hypotheses; 1987 May; 23(1):51-8. PubMed ID: 3614003
    [Abstract] [Full Text] [Related]

  • 5. Hypoxemic fetoplacental vasoconstriction: a graduated response to reduced oxygen conditions in the human placenta.
    Ramasubramanian R, Johnson RF, Downing JW, Minzter BH, Paschall RL.
    Anesth Analg; 2006 Aug; 103(2):439-42, table of contents. PubMed ID: 16861430
    [Abstract] [Full Text] [Related]

  • 6. Determination of adenosine in fetal perfusates of human placental cotyledons using fluorescence derivatization and reversed-phase high-performance liquid chromatography.
    Slegel P, Kitagawa H, Maguire MH.
    Anal Biochem; 1988 May 15; 171(1):124-34. PubMed ID: 3407908
    [Abstract] [Full Text] [Related]

  • 7. L-arginine prevents hypoxia-induced vasoconstriction in dual-perfused human placental cotyledons.
    Bednov A, Espinoza J, Betancourt A, Vedernikov Y, Belfort M, Yallampalli C.
    Placenta; 2015 Nov 15; 36(11):1254-9. PubMed ID: 26342955
    [Abstract] [Full Text] [Related]

  • 8. Hypoxic fetoplacental vasoconstriction in humans is mediated by potassium channel inhibition.
    Hampl V, Bíbová J, Stranák Z, Wu X, Michelakis ED, Hashimoto K, Archer SL.
    Am J Physiol Heart Circ Physiol; 2002 Dec 15; 283(6):H2440-9. PubMed ID: 12388256
    [Abstract] [Full Text] [Related]

  • 9. Chronic hypoxia increases fetoplacental vascular resistance in rat placenta perfused with blood.
    Kafka P, Vajnerova O, Hampl V.
    Bratisl Lek Listy; 2016 Dec 15; 117(10):583-586. PubMed ID: 27826973
    [Abstract] [Full Text] [Related]

  • 10. Micronized progesterone reduces vasoconstriction in the placenta.
    Miller NR, Dolinsky BM, Napolitano PG.
    J Matern Fetal Neonatal Med; 2015 Sep 15; 28(13):1581-4. PubMed ID: 25204334
    [Abstract] [Full Text] [Related]

  • 11. Rho-kinase inhibition attenuates acute hypoxic fetoplacental vasoconstriction in the rat.
    Kafka P, Vajnerová O, Herget J, Hampl V.
    Physiol Res; 2012 Sep 15; 61 Suppl 2(Suppl 2):S43-8. PubMed ID: 23130902
    [Abstract] [Full Text] [Related]

  • 12. Dual messenger function for prostaglandin E2 (PGE2) in human placenta.
    Sastry BV, Hemontolor ME, Chance MB, Johnson RF.
    Cell Mol Biol (Noisy-le-grand); 1997 May 15; 43(3):417-24. PubMed ID: 9193797
    [Abstract] [Full Text] [Related]

  • 13. The dynamic placenta: I. Hypothetical model of a placental mechanism matching local fetal blood flow to local intervillus oxygen delivery.
    Talbert D, Sebire NJ.
    Med Hypotheses; 2004 May 15; 62(4):511-9. PubMed ID: 15050098
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetic studies of enalaprilat in the in vitro perfused human placental lobule system.
    Miller RK, Jessee L, Barrish A, Gilbert J, Manson JM.
    Teratology; 1998 May 15; 58(3-4):76-81. PubMed ID: 9802186
    [Abstract] [Full Text] [Related]

  • 15. Continuous infusion of 17-hydroxyprogesterone caproate into either the fetoplacental or intervillous circulation of a placental cotyledon attenuates vasoconstriction of the fetoplacental arteries by thromboxane mimetic U46619.
    Zelig CM, Paonessa DJ, Hoeldtke NJ, Hill DL, Foglia LM, Napolitano PG.
    Am J Obstet Gynecol; 2010 Feb 15; 202(2):189.e1-5. PubMed ID: 20004884
    [Abstract] [Full Text] [Related]

  • 16. Hypothesis: selective phosphodiesterase-5 inhibition improves outcome in preeclampsia.
    Downing JW, Ramasubramanian R, Johnson RF, Minzter BH, Paschall RL, Sundell HW, Engelhardt B, Lewis R.
    Med Hypotheses; 2004 Feb 15; 63(6):1057-64. PubMed ID: 15504576
    [Abstract] [Full Text] [Related]

  • 17. Reactivity of human placental chorionic plate vessels from pregnancies complicated by intrauterine growth restriction (IUGR).
    Wareing M, Greenwood SL, Fyfe GK, Baker PN.
    Biol Reprod; 2006 Oct 15; 75(4):518-23. PubMed ID: 16707770
    [Abstract] [Full Text] [Related]

  • 18. Fetoplacental vascular tone is modified by magnesium sulfate in the preeclamptic ex vivo human placental cotyledon.
    Kovac CM, Howard BC, Pierce BT, Hoeldtke NJ, Calhoun BC, Napolitano PG.
    Am J Obstet Gynecol; 2003 Sep 15; 189(3):839-42. PubMed ID: 14526326
    [Abstract] [Full Text] [Related]

  • 19. Influence of perfusate PO2 on hypoxic pulmonary vasoconstriction in rats.
    Marshall C, Marshall BE.
    Circ Res; 1983 Jun 15; 52(6):691-6. PubMed ID: 6861287
    [Abstract] [Full Text] [Related]

  • 20. Pregestational diabetes increases fetoplacental vascular resistance in rats.
    Vajnerova O, Kafka P, Kratzerova T, Chalupsky K, Hampl V.
    Placenta; 2018 Mar 15; 63():32-38. PubMed ID: 29486854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.